Novanta outlays $1.45bn for Riverpoint Medical buyout
Novanta has agreed to acquire Riverpoint Medical for an upfront price of $1.2bn to expand its portfolio into the minimally …
Post
-
-
FDA clears Xenix Medical’s Lux fusion system
Xenix Medical has obtained US Food and Drug Administration (FDA) clearance for its Lux expandable lumber interbody fusion system and …
-
Stevanato unveils Deora pen injector for diabetes and weight management
Stevanato Group has introduced Deora, a multi-use, fixed-dose pen injector designed to support subcutaneous delivery of therapies for diabetes and …
-
Medtronic secures CE mark for Stealth AXiS system for ENT surgery
Medtronic has received the CE mark for its Stealth AXiS surgical system, clearing the way for its use in ear, …
-
Women’s health apps: governance and transparency key to success as opportunities bloom
As the use of digital health apps continues to surge across both the specialist health and general wellness spaces, so …
-
FDA issues early alert for GE HealthCare’s infant resuscitation systems
The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ device issue with certain GE …
-
ADA26: Dexcom’s G7 CGM helps TD2 diabetics not on insulin manage glucose levels
New data from Dexcom has demonstrated the benefit of its G7 continuous glucose monitor (CGM) in type 2 diabetes (TD2) …
-
Tandem secures CE mark for AID systems in T2D and T1D with pregnancy
Tandem Diabetes Care has received a CE mark for expanded indications of its automated insulin delivery (AID) systems in Europe. The …
-
Insulet reports new data for Omnipod 6 and FCL systems
Insulet has reported results from two clinical studies, STRIVE and EVOLUTION 3, assessing its upcoming Omnipod 6 automated insulin delivery …
-
Zepto Life Technology’s mould infection panel obtains FDA breakthrough designation
Zepto Life Technology’s invasive mould detection test has secured a breakthrough device designation from the US Food and Drug Administration …
-
Sophia Genetics and MSK join forces to develop precision oncology hub
SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center (MSK) have signed a memorandum of understanding (MoU) that will set in …
-
Roche develops RUO PCR assay to detect rare Ebola Bundibugyo virus
Roche has announced the rapid development of a research-use-only (RUO) molecular polymerase chain reaction (PCR) test to detect the rare …
-
FDA approves GE HealthCare’s MIM Contour ProtégéAI+ 2.0 software
GE HealthCare has received 510(k) clearance from the US Food and Drug Administration (FDA) for its medical imaging management (MIM) …
-
CereVasc raises $85m to advance hydrocephalus treatment
CereVasc has raised $85m, providing the clinical stage company with a cash runway to support the ongoing development of its …
-
ResMed completes $340m Noctrix Health acquisition
Noctrix Health has been acquired by ResMed in a $340m deal, representing the first portfolio company exit for Angelini Ventures, …
